Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guideline

Cox, Miriam F.; Mackenzie, Strachan; Low, Ryan; Brown, Michael; Sanchez, Emilie; Carr, Aisling; Carpenter, Ben; Bishton, Mark; Duncombe, Andrew; Akpabio, Akpabio; Kulasekararaj, Austin; Sin, Fang En; Jones, Alexis; Kavirayani, Akhila; Sen, Ethan S.; Quick, Vanessa; Dulay, Gurdeep S.; Clark, Sam; Bauchmuller, Kris; Tattersall, Rachel S.; Manson, Jessica J.

Abstract

Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome characterised by persistently activated cytotoxic lymphocytes and macrophages, which, if untreated, leads to multiorgan dysfunction and death. HLH should be considered in any acutely unwell patient not responding to treatment as expected, with prompt assessment to look for what we term the three Fs—fever, falling blood counts, and raised ferritin. Worldwide, awareness of HLH and access to expert management remain inequitable. Terminology is not standardised, classification criteria are validated in specific patient groups only, and some guidelines rely on specialised and somewhat inaccessible tests. The consensus guideline described in this Health Policy was produced by a self-nominated working group from the UK network Hyperinflammation and HLH Across Speciality Collaboration (HiHASC), a multidisciplinary group of clinicians experienced in managing people with HLH. Combining literature review and experience gained from looking after patients with HLH, it provides a practical, structured approach for all health-care teams managing adult (>16 years) patients with possible HLH. The focus is on early recognition and diagnosis of HLH and parallel identification of the underlying cause. To ensure wide applicability, the use of inexpensive, readily available tests is prioritised, but the role of specialist investigations and their interpretation is also addressed.

• Journal Article Type: Article
• Acceptance Date: Oct 1, 2023
• Online Publication Date: Nov 29, 2023
• Publication Date: Jan 1, 2024
• Deposit Date: Nov 30, 2023
• Publicly Available Date: May 30, 2024
• Journal: The Lancet Rheumatology
• Electronic ISSN: 2665-9913
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 6
• Issue: 1
• Pages: e51-e62
• DOI: https://doi.org/10.1016/s2665-9913%2823%2900273-4
• Keywords: Immunology; Immunology and Allergy; Rheumatology
• Public URL: https://nottingham-repository.worktribe.com/output/27867585
• Publisher URL: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00273-4/fulltext
• Related Public URLs: https://www.sciencedirect.com/science/article/abs/pii/S2665991323002734?via%3Dihub